Cargando…
Costs and health impact of delayed implementation of a national hepatitis B treatment program in China
BACKGROUND: Hepatitis B virus (HBV) infection is a leading public health problem in China. COVID-19 pandemic has interrupted the delivery of health care interventions worldwide, including HBV infection control. METHODS: In this study, we used a Markov model to quantify the costs and population healt...
Autores principales: | Toy, Mehlika, Hutton, David, Jia, Jidong, So, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Global Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260492/ https://www.ncbi.nlm.nih.gov/pubmed/35796158 http://dx.doi.org/10.7189/jogh.12.04043 |
Ejemplares similares
-
Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China
por: Toy, Mehlika, et al.
Publicado: (2015) -
Cost-Effectiveness of Hepatitis B Testing and Vaccination of Adults Seeking Care for Sexually Transmitted Infections
por: Hutton, David W., et al.
Publicado: (2022) -
Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income
por: Tordrup, David, et al.
Publicado: (2020) -
Gaps and Disparities in Chronic Hepatitis B Monitoring and Treatment in the United States, 2016-2019
por: Pham, Thi T. Hang, et al.
Publicado: (2023) -
Impact of the national hepatitis B immunization program in China: a modeling study
por: Liu, Zhixi, et al.
Publicado: (2022)